Ann: Data Presentations at Upcoming Industry Conferences, page-27

Hi Joe, I recall going to a Primo preso at the Hilton in Brisbane where MV spoke, before he was CEO.
That was back in the days when ovarian C was the flagship. That path did not eventuate.
So now we have a new product, but the same story.
From my discussion with him back then he liked Australia so I wouldn't put too much credence in a visit to our shores. It is his job to talk the talk.
I wouldn't be so crass as to call it an unpalatable desert (junket) but why would I be cynical.
As a long term holder, since 2003 at a price of 36cents, and several cr raisings since, I would certainly like some positive news, but I learnt a while back not to put the cart before the horse.
Good luck to you and your biotec investing, it is a long & bumpy road.